BiomX Inc (PHGE)

Dec 20, 2024

BitMart Research: BMX 2024 Annual Report - GlobeNewswire Inc.

Dec 20, 2024

Dec 18, 2024

BiomX Inc. Regains Compliance with NYSE American Listing Standards - Defense World

Dec 18, 2024

Dec 16, 2024

BiomX regains NYSE compliance - Investing.com

Dec 16, 2024

Dec 16, 2024

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards - The Manila Times

Dec 16, 2024

Dec 16, 2024

BiomX Regains NYSE American Listing Compliance After Meeting All Standards - StockTitan

Dec 16, 2024

Nov 21, 2024

BiomX (NYSEAMERICAN:PHGE) Stock Price Down 12.2% – Should You Sell? - Defense World

Nov 21, 2024

Nov 20, 2024

BiomX (PHGE) 5-Day RSI : 13.43 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Nov 16, 2024

BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World

Nov 16, 2024

Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India

Nov 15, 2024

Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks

Nov 15, 2024

Nov 14, 2024

BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times

Nov 14, 2024

Nov 14, 2024

BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World

Nov 13, 2024

Nov 12, 2024

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire

Nov 12, 2024

Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India

Nov 01, 2024

Oct 25, 2024

Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India

Oct 25, 2024

Oct 24, 2024

Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 23, 2024

BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat

Oct 23, 2024

Oct 19, 2024

BiomX announces a mandatory unit separation - MSN

Oct 19, 2024

Oct 16, 2024

BiomX announces mandatory unit separation - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

BiomX Announces a Mandatory Unit Separation - The Manila Times

Oct 15, 2024

Oct 09, 2024

BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance

Oct 09, 2024

Oct 05, 2024

BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World

Oct 05, 2024

Oct 03, 2024

Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com

Oct 03, 2024

Oct 03, 2024

Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa

Oct 03, 2024

Oct 02, 2024

BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World

Oct 02, 2024

Sep 26, 2024

BiomX Shares Phage Therapy Advances and Vision - TipRanks

Sep 26, 2024

Sep 26, 2024

Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR

Sep 26, 2024

Sep 20, 2024

BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance

Sep 20, 2024

Sep 18, 2024

BiomX to present data from Phase 1b/2a study of BX004 - TipRanks

Sep 18, 2024

Sep 18, 2024

BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire

Sep 18, 2024

Sep 18, 2024

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan

Sep 18, 2024

Sep 11, 2024

Biomx stock plunges to 52-week low, hits $1.05 - Investing.com

Sep 11, 2024

Sep 10, 2024

BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat

Sep 10, 2024

Sep 10, 2024

BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World

Sep 10, 2024

Sep 06, 2024

Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2024-2031: Enbiotix, Inc., Nextbiotics, - EIN News

Sep 06, 2024

Sep 04, 2024

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 04, 2024

Sep 04, 2024

PHGEBiomX Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024

Sep 04, 2024

Biomx stock plunges to 52-week low at $1.15 amid market challenges - Investing.com

Sep 04, 2024

Sep 03, 2024

BiomX to Present Positive Phase 1b/2a Clinical Trial Data - GlobeNewswire

Sep 03, 2024

Sep 03, 2024

BiomX to present cinical trial data for BX004 at ERS - TipRanks

Sep 03, 2024

Sep 03, 2024

BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024 - StockTitan

Sep 03, 2024

Aug 27, 2024

Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Drops By 92.9% - MarketBeat

Aug 27, 2024